Warning: The NCBI web site requires JavaScript to function. more...
Rapid construction of a dendritic cell vaccine through physical perturbation and apoptotic malignant T cell loading.
Salskov-Iversen M, Berger CL, Edelson RL.
J Immune Based Ther Vaccines. 2005 Jul 19;3:4.
Related citations
Improved generation of anti-tumor immunity by antigen dose limitation.
Shofner JD, Vasquez JG, Berger CL, Edelson RL.
J Immune Based Ther Vaccines. 2007 Feb 9;5:2.
Development of immunogenic tumor-loaded dendritic cells through physical perturbation and apoptotic cell loading.
Shen X, Berger CL, Tigelaar R, Edelson RL.
Immunol Invest. 2008;37(8):798-821.
Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy.
Thumann P, Lüftl M, Moc I, Bagot M, Bensussan A, Schuler G, Jenne L.
Br J Dermatol. 2003 Dec;149(6):1128-42.
The life cycle of cutaneous T cell lymphoma reveals opportunities for targeted drug therapy.
Berger CL, Edelson R.
Curr Cancer Drug Targets. 2004 Nov;4(7):609-19. Review.
The growth of cutaneous T-cell lymphoma is stimulated by immature dendritic cells.
Berger CL, Hanlon D, Kanada D, Dhodapkar M, Lombillo V, Wang N, Christensen I, Howe G, Crouch J, El-Fishawy P, Edelson R.
Blood. 2002 Apr 15;99(8):2929-39.
Induction of human tumor-loaded dendritic cells.
Berger CL, Xu AL, Hanlon D, Lee C, Schechner J, Glusac E, Christensen I, Snyder E, Holloway V, Tigelaar R, Edelson RL.
Int J Cancer. 2001 Feb 15;91(4):438-47.
[Effects of ovarian carcinoma cells on the maturation and function of human dendritic cells].
Li CD, Zhang WY, Yuan CL, Han LY.
Zhonghua Yi Xue Za Zhi. 2009 Mar 10;89(9):630-4. Chinese.
Transimmunization, a novel approach for tumor immunotherapy.
Berger CL, Hanlon D, Kanada D, Girardi M, Edelson RL.
Transfus Apher Sci. 2002 Jun;26(3):205-16. Review.
[In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH, Ye Q, Hu ZQ, Ye ZQ, Yu X, Shen GX.
Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):481-5. Chinese.
Transimmunization for cutaneous T cell lymphoma: a Phase I study.
Girardi M, Berger CL, Wilson LD, Christensen IR, Thompson KR, Glusac EJ, Edelson RL.
Leuk Lymphoma. 2006 Aug;47(8):1495-503.
Generation of mature dendritic cells with unique phenotype and function by in vitro short-term culture of human monocytes in the presence of interleukin-4 and interferon-beta.
Zhang LF, Okuma K, Tanaka R, Kodama A, Kondo K, Ansari AA, Tanaka Y.
Exp Biol Med (Maywood). 2008 Jun;233(6):721-31. Epub 2008 Apr 11.
TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses.
Iwamoto S, Iwai S, Tsujiyama K, Kurahashi C, Takeshita K, Naoe M, Masunaga A, Ogawa Y, Oguchi K, Miyazaki A.
J Immunol. 2007 Aug 1;179(3):1449-57.
Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO.
Williams CA, Harry RA, McLeod JD.
Immunology. 2008 May;124(1):89-101. Epub 2007 Dec 7.
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
von Euw EM, Barrio MM, Furman D, Bianchini M, Levy EM, Yee C, Li Y, Wainstok R, Mordoh J.
J Transl Med. 2007 Apr 20;5:19.
A sea urchin lectin, SUL-1, from the Toxopneustid sea urchin induces DC maturation from human monocyte and drives Th1 polarization in vitro.
Takei M, Nakagawa H.
Toxicol Appl Pharmacol. 2006 May 15;213(1):27-36. Epub 2005 Sep 28.
Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation.
Wang YS, Chi KH, Chu RM.
Vet Immunol Immunopathol. 2007 Aug 15;118(3-4):186-98. Epub 2007 Jun 2.
Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli.
Bechetoille N, André V, Valladeau J, Perrier E, Dezutter-Dambuyant C.
J Leukoc Biol. 2006 Jul;80(1):45-58. Epub 2006 Apr 13.
Imatinib mesylate minimally affects bcr-abl+ and normal monocyte-derived dendritic cells but strongly inhibits T cell expansion despite reciprocal dendritic cell-T cell activation.
Boissel N, Rousselot P, Raffoux E, Cayuela JM, Soulier J, Mooney N, Charron D, Dombret H, Toubert A, Rea D.
J Leukoc Biol. 2006 Apr;79(4):747-56. Epub 2006 Feb 3.
Abnormal cytokine production by circulating monocytes and dendritic cells of myeloid origin in ART-treated HIV-1+ patients relates to CD4+ T-cell recovery and HCV co-infection.
Almeida M, Cordero M, Almeida J, Orfao A.
Curr HIV Res. 2007 May;5(3):325-36.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on